Literature DB >> 22580813

Role of diffusion-weighted magnetic resonance imaging in prostate cancer evaluation.

D Rinaldi1, F Fiocchi, G Ligabue, G Bianchi, P Torricelli.   

Abstract

PURPOSE: The authors analysed the role of diffusion-weighted imaging (DWI) as an additional tool in magnetic resonance (MR) evaluation of prostate cancer.
MATERIALS AND METHODS: Forty-one patients with suspected prostate cancer underwent MR imaging (1.5 Tesla). A DWI sequence was added to the standard morphological protocol, with a maximum b value of 1,000 s/mm(2). Diffusion maps were obtained, and the apparent diffusion coefficient (ADC) was calculated by drawing a region of interest (ROI) over healthy tissue and areas suspicious for malignancy. Histology was considered the gold standard.
RESULTS: The areas correctly classified by MR imaging (42/51) had a low signal intensity on T2-weighted imaging and low ADC value (0.99 ± 0.15 mm(2)/s; p<0.01) compared with the healthy peripheral zone (PZ) (1.73 ± 0.27 mm(2)/s; p<0.01). Nine areas classified as suspicious for malignancy on T2-weighted sequences showed high ADC (1.44 ± 0.06 mm(2)/s; p<0.01) and were confirmed to be disease free by subsequent histological examination. The accuracy of morphofunctional MR imaging was 81.6% compared with 73.7% of the morphological analysis alone.
CONCLUSIONS: The addition of DWI to the standard protocol increases the overall diagnostic performance of MR imaging in detecting prostatic cancer. Thus, DWI can help the clinician determine the most appropriate management strategy for the patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580813     DOI: 10.1007/s11547-012-0832-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  20 in total

1.  Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.

Authors:  Stefan A Reinsberg; Geoffrey S Payne; Sophie F Riches; Sue Ashley; Jonathan M Brewster; Veronica A Morgan; Nandita M deSouza
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

2.  Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences.

Authors:  Piotr Kozlowski; Silvia D Chang; S Larry Goldenberg
Journal:  Magn Reson Imaging       Date:  2007-06-13       Impact factor: 2.546

3.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

4.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.

Authors:  Huadong Miao; Hiroshi Fukatsu; Takeo Ishigaki
Journal:  Eur J Radiol       Date:  2006-11-07       Impact factor: 3.528

5.  Diffusion-weighted MRI of urinary bladder and prostate cancers.

Authors:  Ozgür Kiliçkesmez; Tan Cimilli; Ercan Inci; Arda Kayhan; Sibel Bayramoğlu; Neslihan Taşdelen; Nevzat Gürmen
Journal:  Diagn Interv Radiol       Date:  2009-06       Impact factor: 2.630

6.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.

Authors:  Bashar Issa
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

Review 7.  DW-MRI of the urogenital tract: applications in oncology.

Authors:  G Petralia; H C Thoeny
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

8.  High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio.

Authors:  Kazuhiro Kitajima; Yasushi Kaji; Kagayaki Kuroda; Kazuro Sugimura
Journal:  Magn Reson Med Sci       Date:  2008       Impact factor: 2.471

Review 9.  Diffusion-weighted MRI in the body: applications and challenges in oncology.

Authors:  Dow-Mu Koh; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2007-06       Impact factor: 3.959

Review 10.  Multidisciplinary functional MR imaging for prostate cancer.

Authors:  Jeong Kon Kim; Yun-Jin Jang; Gyunggoo Cho
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more
  5 in total

1.  Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.

Authors:  Valeria Panebianco; Flavio Barchetti; Alessandro Sciarra; Daniela Musio; Valerio Forte; Vincenzo Gentile; Vincenzo Tombolini; Carlo Catalano
Journal:  Eur Radiol       Date:  2013-02-02       Impact factor: 5.315

2.  Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated methods.

Authors:  Nathan Hearn; John Blazak; Philip Vivian; Dinesh Vignarajah; Katelyn Cahill; Daisy Atwell; Jim Lagopoulos; Myo Min
Journal:  Br J Radiol       Date:  2021-01-28       Impact factor: 3.039

Review 3.  The value of diffusion-weighted imaging in the detection of prostate cancer: a meta-analysis.

Authors:  Chen Jie; Liu Rongbo; Tan Ping
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

4.  Is dynamic contrast enhancement still necessary in multiparametric magnetic resonance for diagnosis of prostate cancer: a systematic review and meta-analysis.

Authors:  Zhen Liang; Rui Hu; Yongjiao Yang; Neng An; Xiaoxin Duo; Zheng Liu; Shangheng Shi; Xiaoqiang Liu
Journal:  Transl Androl Urol       Date:  2020-04

5.  Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness.

Authors:  Andrei Lebovici; Silviu A Sfrangeu; Diana Feier; Cosmin Caraiani; Ciprian Lucan; Mihai Suciu; Florin Elec; Gheorghita Iacob; Mircea Buruian
Journal:  BMC Med Imaging       Date:  2014-05-10       Impact factor: 1.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.